EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Immature Sword Bean (Canavalia gladiata) Pod Alleviates Allergic Rhinitis (A Double-Blind Trial) Through PI3K/Akt/mTOR Signaling

Hye-Jeong Hwang iD, Hyeock Yoon, Joo-Hyung Cho, Seong Lee, Kyung-A Hwang, Young Jun Kim

Nutrients · 2025

DOI: 10.3390/nu17030468 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Hye-Jeong Hwang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Agrofood Resources, National Institute of Agricultural Sciences, Rural Development Administration, Wanju-gun 55365, Republic of Korea. Hauptthemen laut MEDLINE: Plant Extracts, Proto-Oncogene Proteins c-akt, TOR Serine-Threonine Kinases, Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Program for Agricultural Science & Technology Development, National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Allergic rhinitis is an IgE-mediated condition of nasal congestion, runny nose, and sneezing which significantly impairs the quality of life. Current treatments, including antihistamines, often have long-term side effects, leading patients to seek safer alternatives.

Objectives

Therefore, in this study, we aimed to evaluate the symptom relief efficacy of immature sword bean pod (SBP) extract, a natural material, in patients with allergic rhinitis, explore the mechanisms by which SBP regulates allergic immune responses, and evaluate its efficacy and safety as a functional ingredient in the management of allergic rhinitis.

Methods

In a double-blind, placebo-controlled, randomized trial involving 64 participants with perennial allergic rhinitis, the subjects were assigned to receive either SBP or placebo orally for six weeks.

Results

The SBP group exhibited significant improvements in nasal congestion (interaction p = 0.031), RQLQ (interaction p = 0.001), sleep (interaction p = 0.004), systemic reaction (interaction p = 0.002), daily life (interaction p = 0.047), and nasal symptoms (interaction p = 0.002). SBP treatment in EoL-1 and HMC-1 cells also led to a notable reduction in eosinophil cationic protein levels (p < 0.05), a key biomarker of allergic inflammation, by inhibiting PI3K/Akt/mTOR activation, resulting in decreased eosinophil activity.

Conclusions

These findings suggest that the SBP extract is a promising natural treatment for allergic rhinitis, offering both efficacy and safety by improving key symptoms and reducing inflammatory responses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinasesRhinitis, AllergicHumansDouble-Blind MethodMaleFemaleAdultSignal TransductionMiddle AgedYoung AdultTreatment Outcome

Stichwörter der Autor:innen

Canavalia gladiataallergic rhinitiseosinophil cationic proteinimmature sword bean pod

Substanzen

Plant ExtractsProto-Oncogene Proteins c-aktTOR Serine-Threonine KinasesPhosphatidylinositol 3-KinasesMTOR protein, human

Autor:innen und Institutionen

  • Department of Agrofood Resources, National Institute of Agricultural Sciences, Rural Development Administration, Wanju-gun 55365, Republic of Korea.
  • Department of Food and Biotechnology, Korea University, Sejong-si 30019, Republic of Korea.
  • Myongji Bioefficacy Research Center, Myongji University, Yongin-si 17058, Republic of Korea.
  • Biomedical Research Institute, Dankook University Hospital, Cheonan-si 31116, Republic of Korea.

ORCID-Profile: Hye-Jeong Hwang

Förderung

  • Research Program for Agricultural Science & Technology Development
  • National Institute of Agricultural Sciences, Rural Development Administration, Republic of Korea

Zitieren

APA

Hwang, H. J., Yoon, H., Cho, J. H., Lee, S., Hwang, K. A., & Kim, Y. J. (2025). Immature Sword Bean (Canavalia gladiata) Pod Alleviates Allergic Rhinitis (A Double-Blind Trial) Through PI3K/Akt/mTOR Signaling. Nutrients. https://doi.org/10.3390/nu17030468

Vancouver

Hwang HJ, Yoon H, Cho JH, Lee S, Hwang KA, Kim YJ. Immature Sword Bean (Canavalia gladiata) Pod Alleviates Allergic Rhinitis (A Double-Blind Trial) Through PI3K/Akt/mTOR Signaling. Nutrients. 2025. doi:10.3390/nu17030468

BibTeX
@article{Hwang2025,
  author = {Hwang, Hye-Jeong and Yoon, Hyeock and Cho, Joo-Hyung and Lee, Seong and Hwang, Kyung-A and Kim, Young Jun},
  title = {Immature Sword Bean (Canavalia gladiata) Pod Alleviates Allergic Rhinitis (A Double-Blind Trial) Through PI3K/Akt/mTOR Signaling},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17030468}
}
Kostenlos starten →